MedPath

Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic

Not Applicable
Recruiting
Conditions
Prevalence
Social Distance
Postpartum Depression
Covid19
Registration Number
NCT04487171
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

Postpartum depression (PPD) represent around 15% of birth in developed countries. The context of the COVID-19 epidemy represents a possible source of additional emotional distress. The objective of this study is to determine the screening prevalence and risk factors of postpartum depression, among women who deliver in fourth hospital in the North of France in the context of the COVID epidemy.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
248
Inclusion Criteria
  • Single baby delivery
  • alive new born child without admission in neonatal intensive care unit
  • French-speaking mother
  • mother older than 18 years old
Exclusion Criteria
  • Patients who refuses the inclusion

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Variation of prevalence of clinically-significant post-partum depressive symptomsup to 35 days after delivery

Variation of prevalence of clinically-significant post-partum depressive symptoms

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Amiens

🇫🇷

Amiens, France

© Copyright 2025. All Rights Reserved by MedPath